Current PSR (price to sales ratio) is less than 1VMD is 3.4 and industry high is around 20. Average in the current healthcare sector is 1.4 according Scotia Itrade info. If we are average right now - we should be 40% higher in PPS right now. I feel we are now well above average amongst our peers. Everybody seems to agree that we are grossly undervalued and research reports that will be coming out from Heywood Securities and Canacord in the next while will varify that even more. Soon we will have 3 investment houses with a target price of around $3.00 per share.